Identification of a Novel Inhibitor against Middle East Respiratory Syndrome Coronavirus

The Middle East respiratory syndrome coronavirus (MERS-CoV) was first isolated in 2012, and circulated worldwide with high mortality. The continual outbreaks of MERS-CoV highlight the importance of developing antiviral therapeutics. Here, we rationally designed a novel fusion inhibitor named MERS-fi...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Yaping, Zhang, Huaidong, Shi, Jian, Zhang, Zhe, Gong, Rui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618021/
https://www.ncbi.nlm.nih.gov/pubmed/28906430
http://dx.doi.org/10.3390/v9090255

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618021/
https://www.ncbi.nlm.nih.gov/pubmed/28906430
http://dx.doi.org/10.3390/v9090255

Ejemplares similares